FAAH, fatty acid amide hydrolase, 2166

N. diseases: 177; N. variants: 8
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs11576941
rs11576941
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0200638
Disease:
Eosinophil count procedure
0.700 GeneticVariation GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
dbSNP: rs772931153
rs772931153
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0006142
Disease:
Malignant neoplasm of breast
0.700 GeneticVariation UNIPROT
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE This may explain the greater vulnerability for addiction and obesity in individuals with C385A genetic variant and by extension, suggest that a D3 antagonism strategy in substance use disorders should consider FAAH C385A polymorphism. 31775159 2020
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE The influence of the fatty acid amide hydrolase 385C>A single nucleotide polymorphisms on obesity susceptibility. 31286394 2019
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE The FAAH SNP rs324420 was associated with increased obesity (three studies). 30129173 2019
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE It has been demonstrated that the polymorphism 385 C/A of FAAH (fatty acid amide hydrolase) was associated with obesity and metabolic disorders. 22609216 2013
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE As we observed some evidence for an association of the FAAH variants rs2295632 rs324420 with early onset but not adult obesity, we conclude that the FAAH variants analyzed here at least do not seem to play a major role in the etiology of obesity within our samples. 20044928 2010
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE It has been demonstrated that the polymorphism 385 C/A of fatty acid amide hydrolase was associated with obesity. 20102775 2010
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE The aim of our study was to investigate the relationship of polymorphism (cDNA 385 C-->A) of FAAH gene on obesity parameters in patients with diabetes mellitus type 2. 20056290 2010
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE An association between Pro129Thr variant of the FAAH gene and obesity has been described, but various studies have yielded conflicting results. 18819056 2008
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0028754
Disease:
Obesity
0.090 GeneticVariation BEFREE Our results in 5,109 subjects suggest that FAAH Pro129Thr polymorphism may modestly contribute to class III adult obesity in the French population. 20054193 2008
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0085281
Disease:
Addictive Behavior
0.050 GeneticVariation BEFREE This may explain the greater vulnerability for addiction and obesity in individuals with C385A genetic variant and by extension, suggest that a D3 antagonism strategy in substance use disorders should consider FAAH C385A polymorphism. 31775159 2020
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0085281
Disease:
Addictive Behavior
0.050 GeneticVariation BEFREE The common functional single-nucleotide polymorphism (rs324420, C385A) of the endocannabinoid inactivating enzyme fatty acid amide hydrolase (FAAH) has been associated with anxiety disorder relevant phenotype and risk for addictions. 26036940 2015
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C1561826
Disease:
Overweight and obesity
0.050 GeneticVariation BEFREE C385A is a common, functionally active genetic polymorphism of the gene encoding fatty acid amide hydrolase and has been associated with overweight and obesity. 23616186 2013
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C1561826
Disease:
Overweight and obesity
0.050 GeneticVariation BEFREE The Pro129THr, C385A, polymorphism of FAAH gene (rs324420C>A) has been associated with overweight and obesity. 20716455 2011
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C1561826
Disease:
Overweight and obesity
0.050 GeneticVariation BEFREE The Pro129THr, C385A, polymorphism of FAAH gene (rs324420C>A) has been associated with overweight and obesity. 20716455 2011
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C1561826
Disease:
Overweight and obesity
0.050 GeneticVariation BEFREE Recently, it has been shown that the polymorphism 385 C/A of FAAH (fatty acid amide hydrolase) was associated with overweight and obesity. 20065978 2010
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C1561826
Disease:
Overweight and obesity
0.050 GeneticVariation BEFREE The polymorphism 385 C/A of FAAH has been associated with overweight and obesity. 20056290 2010
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0085281
Disease:
Addictive Behavior
0.050 GeneticVariation BEFREE A common single nucleotide polymorphism (C385A) in the human FAAH gene has been associated with increased risk for addiction and obesity. 19103437 2009
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C1561826
Disease:
Overweight and obesity
0.050 GeneticVariation BEFREE We investigated the Pro129Thr variant in relation to overweight and obesity in a relatively large population-based study sample of Danish whites (n=5,801). 17216208 2007
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0085281
Disease:
Addictive Behavior
0.050 GeneticVariation BEFREE Moreover, this mutation appears to have arisen early in human evolution and this study validates the previous link between the FAAH P129T variant and vulnerability to addiction of multiple different drugs. 16972078 2006
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0085281
Disease:
Addictive Behavior
0.050 GeneticVariation BEFREE This SNP, which converts a conserved proline residue in FAAH to threonine (P129T), suggests a potential role for the FAAH-endocannabinoid system in regulating addictive behavior. 15254019 2004
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0242510
Disease:
Drug usage
0.040 GeneticVariation BEFREE In this study we investigated inter-individual differences in mood response to amphetamine in relation to four polymorphisms in the FAAH gene, including the FAAH missense variant rs324420C --> A (Pro129Thr), which was previously found to be associated with street drug use and addictive traits. 19890266 2010
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0242510
Disease:
Drug usage
0.040 GeneticVariation BEFREE The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: studies of drug use and dependence in Caucasians. 17290447 2007
dbSNP: rs324420
rs324420
Entrez Id: 2166
Gene Symbol: FAAH
FAAH
CUI: C0242510
Disease:
Drug usage
0.040 GeneticVariation BEFREE The human fatty acid amide hydrolase (FAAH) missense mutation c.385 C-->A, which results in conversion of a conserved proline residue to threonine (P129T), has been associated with street drug use and problem drug abuse. 16972078 2006